Alicanto Drugs Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimcan MV 1mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimcan MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimcan MV 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
Glimcan MV 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimcan MV 1mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. It is used in the treatment of type 2 diabetes mellitus (DM). This medicine improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by reducing glucose production in the liver and enhancing insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that decreases postprandial (after meal) glucose levels in the body.
Possible side effects associated with Glimcan MV 1mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid using Glimcan MV 1mg/500mg/0.3mg Tablet if you have known allergy to any of the components or excipients of this medicine, or are experiencing moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimcan MV 1mg/500mg/0.3mg Tablet with alcohol is not recommended as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Glimcan MV 1mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk is higher if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications together.
Store this medicine in its original packaging or container, tightly sealed. Adhere to the instructions on the label regarding storage and handling. Do not reuse the medication. Ensure proper disposal by safely discarding unused medication out of reach of pets, children, and unauthorized individuals.